市場調査レポート
商品コード
1492375
頸動脈ステントの市場:タイプ、素材、エンドユーザー別-2024-2030年の世界予測Carotid Stents Market by Type (Balloon-expandable Stents, Self-expanding Stents), Material (Metallic Stents, Polymer Stents), End-user - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
頸動脈ステントの市場:タイプ、素材、エンドユーザー別-2024-2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
|
頸動脈ステント市場規模は、2023年に5億8,822万米ドルと推定され、2024年には6億2,098万米ドルに達し、CAGR 5.88%で2030年には8億7,805万米ドルに達すると予測されています。
頸動脈ステントは、金属メッシュでできた小型のチューブ型器具です。頸動脈の開通を確実にするための医療処置に使用されます。この処置は、頸動脈疾患として知られる動脈壁内部のプラーク蓄積による狭窄のために脳卒中の危険性がある人には不可欠です。脳卒中を含む心血管系疾患の増加により、頸動脈ステントの必要性が高まっています。医師や患者の間で、回復に要する時間が短い低侵襲手術への志向が高まっていることが、頸動脈ステントのニーズと市場成長の原動力となっています。ステント留置術に伴うリスクや合併症が頸動脈ステント市場の成長を阻害しています。より安全で効果的な頸動脈ステントの素材やデザインなど、ステント留置術の技術向上が進み、市場成長の機会が生まれると期待されています。
主な市場の統計 | |
---|---|
基準年[2023] | 5億8,822万米ドル |
予測年[2024] | 6億2,098万米ドル |
予測年 [2030] | 8億7,805万米ドル |
CAGR(%) | 5.88% |
地域別インサイト
南北アメリカは、脳卒中予防に対する高い意識と高度なヘルスケアインフラにより、頸動脈ステントの需要が堅調です。また、心血管障害の原因となる肥満や糖尿病などの生活習慣病の流行も市場を後押ししています。さらに、有利な償還政策と頸動脈ステントの有効性と安全性を向上させるための進行中の臨床試験が、この市場の成長を支えています。APAC地域は頸動脈ステント市場で急速な成長を遂げています。この成長の要因には、医療インフラの改善、ヘルスケアへの支出の増加、心血管健康に関連する疾患に対する意識の向上などがあります。中国やインドを含む国々は人口が多く、医療サービスへのアクセスが向上し始めています。欧州は、確立されたヘルスケアシステムと予防医療に対する高い意識により、頸動脈ステントの主要地域となっています。強力な規制の枠組みや大手ヘルスケア企業の存在も、市場の着実な成長に寄与しています。中東・アフリカは、ヘルスケアへのアクセスが多様で、市場も多様です。裕福な湾岸諸国では医療インフラへの投資が増加しており、市場成長の可能性があります。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは、頸動脈ステント市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略と製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、頸動脈ステント市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査対象期間の累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、頸動脈ステント市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[191 Pages Report] The Carotid Stents Market size was estimated at USD 588.22 million in 2023 and expected to reach USD 620.98 million in 2024, at a CAGR 5.88% to reach USD 878.05 million by 2030.
Carotid stents are small, tube-shaped devices made of metal mesh. They are used in a medical procedure to ensure the carotid arteries remain open. This procedure is essential for individuals at risk of stroke due to the narrowing caused by plaque buildup inside the artery walls, a condition known as carotid artery disease. Increasing inccidences of cardiovascular diseases, including heart strokes, are drivng the need for carotid stents. The growing inclination towards minimally invasive surgeries among doctors and patients that involve shorter recovery time is driving the need for carotid stents and driving market growth. Risks and complications associated with stenting procedures hamper the growth of the carotid stents market. Rising improvements in stenting technology, including the materials and design of carotid stents that make them safer and more effective, are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 588.22 million |
Estimated Year [2024] | USD 620.98 million |
Forecast Year [2030] | USD 878.05 million |
CAGR (%) | 5.88% |
Regional Insights
Americas shows a robust demand for carotid stents due to high awareness of stroke prevention and advanced healthcare infrastructure. The prevalence of lifestyle-related diseases such as obesity and diabetes, which contribute to cardiovascular disorders, also boosts the market. Furthermore, favorable reimbursement policies and ongoing clinical trials to improve the efficacy and safety of carotid stents support growth in this market. The APAC region is experiencing rapid growth in the carotid stents market. Factors contributing to this growth include improving health infrastructure, increasing spending on healthcare, and raising awareness of diseases related to cardiovascular health. Countries including, China and India have large populations beginning to have better access to healthcare services. Europe is a major region for carotid stents due to well-established healthcare systems and high awareness about preventative healthcare. The strong regulatory framework and the presence of leading healthcare companies also contribute to steady market growth. The Middle East and Africa have a diverse market with varying access to healthcare. The wealthier Gulf countries show potential for market growth due to increasing investment in health infrastructure.
Market Insights
The market dynamics represent an ever-changing landscape of the Carotid Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Carotid Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Carotid Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Silk Road Medical Launches Advanced Carotid Stent System in the U.S.
Silk Road Medical, Inc. introduced the Tapered ENROUTE Transcarotid Stent System to U.S. hospitals. This advancement builds on the existing ENROUTE system, featuring new configurations to better align with individual patient anatomies. The system supports the Transcarotid Artery Revascularization (TCAR) procedure, a minimally invasive approach designed to significantly enhance stroke protection while reducing complications. This launch marks a significant step in customized, patient-centered stroke intervention strategies. [Published On: 2024-03-05]
Expanded Medicare Coverage Facilitates Access to Cordis Carotid Stents
Cordis endorsed a new policy by the Centers for Medicare & Medicaid Services (CMS) that extends coverage for minimally invasive carotid artery treatments. This decision enhances patient access to the Precise Pro Rx carotid stent system, developed by Cordis for endovascular carotid therapy. The company commended the medical community for effectively demonstrating the benefits of carotid artery stenting (CAS), underlying its commitment to supporting advancements in cardiovascular health management. [Published On: 2023-10-16]
Breakthrough in Stroke Prevention: Introduction of CGuard Prime by InspireMD
InspireMD, Inc., successfully treated the first patient suffering from carotid artery disease with its innovative CGuard Prime stent. This procedure is part of the company's CGuardians U.S. IDE trial. CGuard Prime represents InspireMD's latest advancement in carotid artery stenting (CAS) technology, showcasing ongoing efforts to enhance stroke prevention strategies. [Published On: 2023-05-01]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Carotid Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Carotid Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Balton Sp. z o. o., Becton, Dickinson and Company, Biotronik SE & Co KG, Boston Scientific Corporation, Cardinal Health, Inc., Contego Medical, Inc., Cook Group Incorporated, InspireMD Inc., Medtronic PLC, MicroPort Scientific Corporation, Silk Road Medical, Inc., Stryker Corporation, W. L. Gore & Associates, Inc., and Zhejiang Barty Medical Technology Co., Ltd..
Market Segmentation & Coverage